Most recently, the targeting of the aryl hydrocarbon receptor (AhR) with gut microbiota phenolic metabolites has been recognized as a crucial mechanism in the prevention and treatment of intestinal diseases [62,63]. This evidence concerns the gene AHR and intestinal disorder.